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Understanding How the Diagnostic Delay of
Spondyloarthritis Differs Between Women and Men: 
A Systematic Review and Metaanalysis
Vega Jovaní, Mar Blasco-Blasco, M. Teresa Ruiz-Cantero, and Eliseo Pascual
ABSTRACT. Objective. To identify empirical evidence of diagnostic delay in spondyloarthritis (SpA), determine
whether sex-related differences persist, and conduct an analysis from that perspective of the possible
causes, including the influence of quality research, in this group of inflammatory rheumatic diseases.
Methods. A systematic review was done of delay in diagnosis of SpA in MEDLINE and EMBASE
and other sources. Study quality was determined in line with the Strengthening The Reporting of
OBservational studies in Epidemiology (STROBE) statement. A metaanalysis of 13 papers reporting
sex-disaggregated data was performed to evaluate sex-related differences in diagnostic delay. The
global effect of diagnostic delay by sex was calculated using means difference (D) through a fixed
effects model.
Results. The review included 23,883 patients (32.3% women) from 42 papers. No significant differ-
ences between the sexes were detected for symptoms at disease onset or during evolution. However,
the mean for delay in diagnosis of SpA showed sex-related differences, being 8.8 years (7.4–10.1)
for women and 6.5 (5.6–7.4) for men (p = 0.01). Only 40% of papers had high quality. A metaanalysis
included 12,073 participants (31.2% women). The mean global effect was D = 0.6 years (0.31–0.89),
indicating that men were diagnosed 0.6 year (7 months) before women. 
Conclusion. Delay in diagnosis of SpA persists, and is longer in women than in men. There are no
significant sex-related differences in symptoms that could explain sex-related differences in diagnostic
delay. Methodological and possible publication bias could result in sex-biased medical practice. 
(J Rheumatol First Release December 15 2016; doi:10.3899/jrheum.160825)
Key Indexing Terms:
SPONDYLOARTHRITIS            SEX DIFFERENCES        SEX BIAS        DIAGNOSTIC DELAY
From the Rheumatology Department, Alicante University General
Hospital, Alicante, and Miguel Hernandez University, Alicante, Spain.
Supported by FEDER-Instituto de Salud Carlos III, Ministerio de Ciencia
e Innovación, Spain (grant PI11/00865).  
V. Jovaní, MD, Rheumatology Department, Alicante University General
Hospital; M. Blasco-Blasco, MPH, Public Health Department, University
of Alicante; M.T. Ruiz-Cantero, MPH, PhD, Public Health Department,
University of Alicante; E. Pascual, Prof. of Medicine (Rheumatology),
Miguel Hernandez University. 
Address correspondence to Dr. V. Jovaní, Sección Reumatología, Hospital
General Universitario de Alicante, C/ Pintor Baeza 12, 03010, Alicante,
Spain. E-mail: vegajovani@yahoo.com
Accepted for publication October 27, 2016.
Spondyloarthritis (SpA) comprises a heterogeneous group of
interrelated inflammatory rheumatic diseases that can affect
the synovium, enthesis of axial and peripheral joints, and
some extraarticular sites. The SpA group includes reactive
arthritis, enteropathic arthritis, juvenile SpA, psoriatic
arthritis (PsA), and ankylosing spondylitis (AS), which was
the first condition to be characterized and is considered the
prototype disease. Initially, the different forms were looked
upon as independent diseases, but similarities in their clinical
characteristics, and later the association of these diseases with
HLA-B27 after its description in 1973, proved that they are
similar or closely related conditions now jointly recognized
as SpA. In earlier studies, AS had been found to be far more
common in men by a ratio of 10:1, but once all the different
forms were considered in conjunction, this ratio narrowed to
2–3:11,2,3. The disease commences with spinal or lumbar
pain, and enthesitis or peripheral arthritis, most often in the
lower limbs. Radiological alterations are slow to appear and
hence underrecognition or considerable diagnostic delay has
been frequent. As a result of the discovery of the association
with HLA-B27, the development of classification criteria for
the different clinical forms, and probably, closer attention,
delay has been reduced in recent years4.
Because of the clearly lower frequency of classical AS in
women, the disease was considered a male disease, prompting
underrecognition in women and resulting in a longer delay to
diagnosis than in men, and this delay continues to be reported
when all the different clinical forms are considered together5.
With recent therapeutic advances, early diagnosis and
knowledge of sex differences have become indispensable.
Several studies have shown that there is a systematic sex bias
in healthcare, partially related to biased research hypotheses
and/or methods due to insensitivity to sex6.
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The most widely used definition of sex bias is the differ-
ential medical treatment of men and women, the effect of
which may be positive, negative, or neutral7. However, for
research purposes, it is useful to define sex bias as a
systematic wrong approach regarding sex insensitivity that
incorrectly considers women and men as similar in the
natural history of disease6. Sex bias in SpA is an interesting
area to study8 because of the longer diagnosis delay in
women and the causes of that delay.
The aim of our present study was to identify empirical
evidence of diagnostic delay in SpA, determine whether
sex-related differences persist, and conduct an analysis from
a sex perspective of the possible causes, including the
influence of quality research, in this group of inflammatory
rheumatic diseases.
MATERIALS AND METHODS
Data sources and literature search. A systematic literature search was
conducted in MEDLINE and EMBASE through natural language. The key
words were spondyloarthropathies, spondyloarthritis, “reiter arthritis”,
“reactive arthritis”, “juvenile spondyloarthropathy”, “ankylosing spondy -
litis”, “enteropathic spondyloarthritis”, (“spondyloarthropathy AND inflam-
matory bowel disease”), (“spondyloarthritis AND inflammatory bowel
disease”), and (“ankylosing spondylitis AND inflammatory bowel
disease”). Each of these was individually combined with: (delay OR
delayed) AND (sex OR gender OR women OR woman) NOT (psoriatic
arthritis). Complemen tary papers potentially eligible were included, a
search through snowballing was performed by cross reference, and 16
studies were identified1,3,8-21. Ultimately, 379 identified papers were
consulted. The search included all material published before April 2016,
regardless of date of publication. 
Study selection. The inclusion criteria were original articles in which SpA
was the main subject, which analyzed delay in diagnosis and included
women. We excluded papers with PsA patients because, although this disease
also shows diagnosis delay, it is less than that found in AS4, probably due to
the presence of psoriasis in two-thirds of patients prior to arthritis. In
addition, papers were excluded if they did not fulfill the study criteria or
consisted of editorials, reviews, case studies, questionnaires, or
diagnostic/therapeutic techniques. Non-English and non-Spanish papers
were excluded.
We obtained 102 papers from MEDLINE and 261 from EMBASE and
16 from other sources. Of these, 226 were eliminated because they were
duplicated, and 111 met the exclusion criteria described above. The other 42
were included in the review (Figure 1).
Data extraction and quality assessment. Two observers (JV and BBM)
performed a content analysis of the 42 original articles finally selected, for
which an information compilation protocol was established and applied,
comprising the following variables:
• Patients: total number of patients and number disaggregated by sex, type
of SpA (axial, peripheral, or mixed), age at onset of disease, age at
diagnosis, duration of disease, HLA-B27 positivity, family history of AS
and social/sex-related causes explaining sex differences in delay in
diagnosis (family/reproductive and/or productive roles, social factors and/or
factors related with medical practice), clinical manifestations at baseline
and later (neck and back pain, peripheral arthritis, enthesitis, and uveitis),
and delay in diagnosis, which was considered as the time difference
between the onset of symptoms and the date of diagnosis by a professional
as established by the Assessment of Spondyloarthritis International Society
(ASAS).
• Study characteristics: design (cross-sectional, cohort, case control), type
of cases (incident, prevalent), data source (hospital, patient group), type of
data (medical history, questionnaire, register), classification criteria (Rome,
New York, modified New York, European Spondyloarthropathy Study
Group, and ASAS).
• The quality of the studies was determined in line with the Strengthening
The Reporting of OBservational studies in Epidemiology (STROBE)
statement (www.strobe-statement.org), a checklist of items that should be
included in reports of observational studies, related to title and abstract, intro-
duction, methods, results, discussion, and other information. Papers were
classified as follows: low quality (< 50%), medium (≥ 50% to < 70%), high
(≥ 70% to < 90%), and excellent (≥ 90%).
Concordance between the 2 observers was computed for all the
variables included in the review. A third observer (RCMT) evaluated
cases of disagreement between observers in the classification of some
variables.
Data analysis and synthesis. First, a descriptive analysis was carried out of
the distribution of the previously mentioned variables. We calculated means
and CI 95% to compare age at onset, age at diagnosis, disease duration, and
diagnostic delay in women and men. Further, to compare sex-related differ-
ences as regards clinical manifestations at onset and during the course of the
disease, we calculated means and CI 95% of the percentages of neck and
back pain, peripheral arthritis, enthesitis, and uveitis. 
Comparisons of the continuous parametric variables were carried out by
Student t test and the nonparametric ones by Mann-Whitney U test. A value
of p < 0.05 was considered significant. Statistical evaluations were
performed by SPSS 15.0 package program.
A metaanalysis was performed to evaluate sex-related differences in
diagnosis delay, in which women were the case group and men the control
one. The main selection criteria were papers that reported information about
median and SD of diagnosis delay by sex. Twenty-five papers did not offer
diagnostic delay disaggregated by sex, 2 papers were excluded because they
did not show SD to calculate the CI, and 1 more was excluded because of
low quality. Of the remaining 14 papers, in 2 studies, the SD from the data
(no. men and women, means for men and women, and statistical signifi-
cance) were calculated assuming similar variances for men and women. One
of the studies22 gave data for 4 subgroups that formed 4 different samples
and these were included in the metaanalysis (southern China with juvenile
AS, southern China with adult AS, northern China with juvenile AS, and
northern China with adult AS). 
Seventeen samples were included in the metaanalysis (Figure 1).
Because delay in diagnosis is a continuous variable, the means difference
(D) and its CI (95%) were used to calculate the global effect of diagnostic
delay by sex. Heterogeneity between the studies was measured using the
chi-squared statistics test; probability value of p < 0.05 was considered statis-
tically significant. 
The I2 statistic was used to quantify the degree of heterogeneity of the
17 samples (14 papers), considering a value over 50% high. Because a
heterogeneity was obtained not only by chi-squared test (p < 0.00001) but
also by I2 statistic = 95% by the randomized effects model, sensitivity
analyses were performed to assess the robustness of the results of the
metaanalysis. Specifically, the influence of effect sizes was assessed by
deletion of each paper to check heterogeneous data that could affect the
overall result. Only 1 paper (Bandinelli, et al23) was identified as the cause
of the entire heterogeneity and it was excluded from the metaanalysis. That
paper observed less diagnostic delay in women than in men, likely related
to higher education, work levels, and peripheral involvement. As Higgins
and Green write, if an obvious reason for the outlying result is apparent, the
study might be removed with more confidence24. This practice is also carried
out in a Cochrane review25.
Then, a second metaanalysis was developed with 16 samples (13 papers).
Publication bias was determined by means of a funnel plot. The metaanalysis
was performed using Review Manager software (Revman version 5.3;
Cochrane Collaboration; http://tech.cochrane.org/revman).
Ethics approval was not required, in accordance with the policy of our
institution.
2 The Journal of Rheumatology 2017; 44:2; doi:10.3899/jrheum.160825
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RESULTS 
Table 1 shows the main characteristics of the 42 studies on
diagnostic delay in SpA included in this systematic
review1,2,3,8-18,19,20,21,22,23,26-36,37-47,48. The review included
23,883 patients (67.6% men, 32.3% women). Prevalent cases
accounted for all studies; 97.6% used a cross-sectional design
and 1 was a cohort study48. Criteria used for patient selection
are shown in Table 1. 
The mean for delay in diagnosis was given in 3 papers that
included women only, and a further 17 studies gave data
disaggregated by sex, indicating statistically significant
differences between women and men in the mean for delay
in diagnosis, with a mean of 8.8 years (7.4–10.1) being
obtained for women and 6.5 (5.6–7.4) for men (p = 0.01).
Thirty papers gave overall data of delay in diagnosis (9 of
them also gave data by sex), and the mean was 6.6 years
(5.9–7.3).
There were no detected significant sex differences in mean
age at onset of disease, age at diagnosis, and mean disease
duration.
3Jovaní, et al: Sex-related SpA diagnosis delay 
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Figure 1. Flowchart of the review process of studies about diagnosis delay of spondyloarthritis (SpA). 
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Table 1. Characteristics of studies of diagnostic delay in spondyloarthritis published between 1976 and 2016.
Author (yr)ref Both Sexes Women Men Study SpA  Study    Info Diagnosis 
N Diagnostic N Diagnostic N Diagnostic Design Type Subject Sources Criteria
Delay, yrs Delay, yrs Delay, yrs Origin
Conigliaro P (2016)26 136 5.2 91 NR 45 NR CS A/P H MR ASAS
Bandinelli F (2016)23 135 NR 44 6.3 ± 1.1 9.9 ± 0.8 CS A/P H MR NY, ASAS
Seo M (2015)27 105 8 (3–4) 24 NR 81 NR CS A/P H MR/Q ASAS
Shahlaee A (2015)28 320 NR 67 8.8 253 8 CS A/P H Q mNY
Zhao J (2015)29 256 3.8 ± 2.0 30 NR 226 NR CS A/P H MR mNY
Guan M (2014)30 J: 50 5.3 ± 5.2 9 NR 41 NR CS A/P H Q mNY
Adult: 89 2.8 ± 3.8 24 NR 65 NR
Bodur H (2012)21 1381 5 ± 6.8 343 5.3 1038 4.9 CS A/P H Q mNY
Ibn Yacoub Y (2012)31 130 NR 43 4.8 87 4.6 CS A/P H MR mNY
Gerdan V (2012)32 393 8.1 ± 8.6 135 NR 258 NR CS A/P H Q mNY
Hamilton L (2011)33 807 8.57 298 NR 509 NR NR H Q mNY
Hajialilo M (2014)34 60 6.2 ± 3.5 7 8.0 ± 4.7 53 5.9 ± 3.3 CS A/P H Q mNY
Chung HY (2011)35 H+: 435 2.7 ± 4.2 212 NR 223 NR CS A/P H MR Amor/ESSG/
H–: 273 3.7 ± 5.1 171 NR 102 NR ASAS/mNY
Slobodin G (2011)36 151 NR 72 5.7 79 5.9 CS A/P H MR ASAS/mNY
Roussou E (2011)37 516 6 344 6.3 172 5.6 CS A/P H Q ESSG/
ASAS/mNY
Ma HJ (2012)22 SC: 113 NR J: 4 10.8 J: 39 8.4 CS A H Q mNY
A: 19 6.2 A: 51 6.6
NC:121 NR J: 6 2.1 J: 35 2.2
A: 17 4.1 A: 63 4
Almodóvar R (2011)14 F:  263 7.7 ± 9 326 NR 990 NR CS A/P H R mNY
S:  1053 7.8 ± 9
Bakland G (2011)38 677 9 126 NR 551 NR CS A/P H MR mNY
Cansu DU (2011)15 102 8.6 36 NR 66 NR CS A/P H MR/Q mNY
Bakland G (2011)16 360 9.4 97 NR 263 NR CS A/P H Q mNY
Almodóvar R (2010)13 SpA: 443 7 ± 9 120 NR 342 NR CS A H R mNY
SpA + FM: 19 8 ± 7
Atagunduz P (2010)19 235 6.7 96 7.4 139 6.2 CS A H MR/C mNY
Özgöcmen S (2009)39 J: 43 5.0 4 NR 39 NR CS A/P H MR mNY
Adult: 279 9.2 53 NR 226 NR
Nazarinia MA (2009)12 98 3.8 ± 0.8 27 NR 71 NR CS A/P H MR/C mNY
Lin YC (2009)40 J: 47 5.7 ± 6.3 6 NR 41 NR CS A/P H Q mNY
Adult: 122 4.6 ± 6.8 21 NR 101 NR
Aggarwal R (2009)8 70 6.7 11 8.9 59 6.5 CS A H Q mNY
Dincer U (2008)41 111 6.0 ± 5.0 8 14.4 ± 14.2 103 5.3 ± 5.6 CS A/P H Q mNY
Reed MD (2008)42 126 8.1 35 10.2 91 7.3 CS A/P H/PC MR/C mNY
Forejtová S (2008)11 1001 9.1 379 NR 622 NR CS A SG Q mNY
Lin Z (2008)43 238 5.9 ± 5.7 38 7.3 ± 7.1 204 5.7 ± 5.4 CS A/P H Q mNY
Aloush V (2007)18 36 NR 18 9.9 18 4.1 CS A H Q mNY
Uppal SS (2006)20 55 7.4 ± 1.9 10 NR 45 NR CS A/P H MR/Q ESSG
Stone M (2005)44 J: 326 15.3 ± 0.7 929 NR 1418 NR CS A SG Q NR
Adult: 2021 7.6 ± 0.2
Feldtkeller E (2003)45 1080 8.8 389 NR 691 NR CS A/P SG Q mNY
Zink A (2000)17 8776 NR 2729 6.1 6047 5.5 CS A/P H MR/Q NR
Koh WH (1993)46 38 7.25 9 NR 29 NR CS A/P H MR           NY
Carbone LD (1992)3 158 5.0 37 NR 121 NR CS A/P H MR         mNY
Ringsdal VS (1989)47 179 NR 48 12.6 131 9.5 CS A/P SG Q              NR
Calin A (1988)2 J: 129 8.7 32 NR 97 NR CS A/P SG Q              NR
E: 129 6.8 36 NR 93 NR
L: 129 7.2 38 NR 91 NR
Riesco M (1985)9 22 NR 22 13.2 0 NR CS A/P H MR         Rome
Marks SH (1983)48 50 NR 25 12.8 25 10.3 CC A/P H MR            NR
Goodman C (1980)10 12 NR 12 11.5 0 NR CS NR H Q              NR
Hill H (1976)1 39 NR 39 10 0 NR CS NR H             MR           NR
J: juvenile; E: early; L: late; SpA: spondyloarthritis; FM: fibromyalgia; SC: Southern China; NC: Northern China; F: familial; S: sporadic; H+: HLA-B27+;
H–:  HLA-B27–negative; CS: cross-sectional; CC: case control; A:  axial; P: peripheral; H: hospital; PC: primary care; C: community; SG: support groups;
MR: medical records; Q: questionnaire; R: register; NY: New York; mNY: modified New York; ESSG: European Spondyloarthropathy Study Group; ASAS:
Assessment of Spondyloarthritis International Society; NR: not reported.
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HLA-B27 positivity was reported in 26 papers and
patients’ family history in 22 papers. In both cases, there was
no detected statistical significance.
Although 9 papers mention the concepts of social
events21,47, social support21,42, social system21, social situa -
tion27,30, effect and consequences11,21, social status15,21,23,28,
social domain and function31, and quality of life21,31, they are
not in relation to social/sex-related causes explaining sex
differences in delay in diagnosis. Only Aggarwal in 2009
adequately discussed the complex range of sex factors
involved in the diagnostic process of SpA according to sex8.
Table 2 with data of review and metaanalysis shows that
no statistically significant differences were detected between
the sexes regarding symptoms at onset of disease, nor were
statistically significant differences detected in symptoms
during evolution of the disease.
As determined according to the different sections of the
STROBE Statement, 11 (26.1%) papers were of low quality,
14 (33.3%) were of medium quality, and 17 (40.4%) were
high quality; these latter were published after 2005. The low
quality of papers was primarily related to the methods
section: 41 papers did not describe any attempts to address
potential sources of bias, 33 papers did not explain how
sample size was calculated, 30 papers did not describe
analytical methods that took sampling strategy into account,
35 papers did not explain how missing data were addressed,
21 papers did not describe any methods used to examine
subgroups and interactions, and 20 papers did not present key
elements of study design early in the paper. In the title or the
abstract, 27 papers did not indicate the study design with a
commonly used term. Regarding the discussion section, 13
papers did not discuss study limitations in terms of sources
of potential bias or inaccuracy (Table 3). 
Figure 2 shows the findings of the first metaanalysis of
the 17 samples or subgroups (13 papers + 4 samples22)
concerning delay in diagnosis of SpA disaggregated by sex;
this included 12,208 participants (3812 women and 8396
men8,17,18,19,21,22,23,28,31,34,36,37,41,42). The mean global effect
was D = 0.77 years (–0.58, 2.12); this result was not statisti-
cally significant, indicating differences in effects across
studies. Therefore, we can say that the average effect reported
did not represent the studies adequately because of hetero-
geneity. Afterward, a sensitivity analysis was performed, and
a study23 with a sample size of 91 men and 44 women
identified as the cause of the entire heterogeneity was
removed, because the diagnostic delay in men (9.909 ±
0.8453) was significantly higher than in women (6.336 ±
1.104; p = 0.0023). In the second metaanalysis, 16 samples
(13 papers) with 12,073 participants (3768 women and 8305
men) were included and the mean global effect obtained was
D = 0.6 years (0.31, 0.89), which indicates men were
diagnosed 0.6 years (7 months and 6 days) before women,
and this result was statistically significant. No heterogeneity
was detected in included studies regarding delay in diagnosis
of AS by sex: chi-squared test (p = 0.57), and I2 statistic =
0%, indicate that there was no variability between studies.
A funnel plot (Figure 3) suggests possible publication bias.
The slight asymmetry at the lower left indicates that there is
a lack of articles with small samples reporting estimations
that women have less diagnosis delay than men. In this case,
5Jovaní, et al: Sex-related SpA diagnosis delay 
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Table 2. Clinical manifestations of spondyloarthritis at onset and during followup.
Systematic Review — 42 Papers
At Onset During Followup
Women Men p Clinical Women Men p
No. Papers % (CI 95%) No. % (CI 95%) Manifestations No. % (CI 95%) No. % (CI 95%)
Papers Papers Papers
6 69.7 (48.6–90.7) 5 69.3 (45.2–93.5) 0.9 Back pain: 8 82.9 (64.3–100) 5 78 (48.5–100) 0.6
lumbar/dorsal
2 19.8 (0–100) 2 14.4 (0–100) 0.4 Neck pain 9 31.3 (13–49.7) 7 24.6 (7.9–41.3) 0.7
4 37.2 (15.2–59.3) 3 33.1 (0–79.1) 0.9 Peripheral arthritis 11 45 (32.5–57.5) 8 34.7 (22.5–47) 0.2
3 5.9 (2.8–9.1) 2 4.1 (0–21.8) 0.2 Enthesitis 5 37.4 (0–79) 5 27.8 (0–59.6) 0.8
1 11.0 1 12.0 NC Uveitis 10 25.1 (12.3–37.9) 7 16.3 (6.2–26.4) 0.3
Metaanalysis — 13 Papers (16 samples)
At Onset During Followup
Women Men p Clinical Women Men p
No. Papers % (CI 95%) No. % (CI 95%) Manifestations No. % (CI 95%) No. % (CI 95%)
Papers Papers Papers
3 69.3 (8.2–100) 3 66.7 (5.6–100) 0.5 Back pain: 3 59.0 (13.4–100) 3 65.0 (10.1–100) 0.8
lumbar/dorsal
2 19.8 (0.100) 2 14.4 (0–100) 0.4 Neck pain 3 27.8 (0–75.3) 3 21.6 (0–68.8) 0.5
2 44.2 (0–100) 2 41.5 (0.100) 0.9 Peripheral arthritis 5 34.4 (10.2–58.5) 5 32.1 (9.6–54.7) 0.9
1 6.5 1 2.7 NC Enthesitis 4 43.8 (0–99.5) 4 30.8 (0–76.2) 0.5
1 11.0 1 12 NC Uveitis 3 15.5 (0–39.8) 3 13.8 (0–33.6) 0.8
NC: not calculated.
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metaanalysis would estimate less diagnosis delay in men than
in women.
DISCUSSION
We found that diagnostic delay in SpA was greater in women
than in men. One possible explanation for this delay in
women could be that they present different clinical symptoms
that might delay the diagnosis, as mentioned in the literature;
however, none of the studies reviewed in connection to
diagnostic delay detected such sex-related differences in
symptoms either at the beginning or during the course of
SpA.
Delay in diagnosis of SpA has been described in
women5,9,10 and in both sexes6,7,11-16,20,26,27,29,30,32,33,35,
38,39,40,44,45,46
, and although Bandinelli23 observed less
diagnostic delay in women than in men, in most of the papers
where delay was compared between men and women, it was
greater in women8,17,18,19,21,22,28,31,34,37,41,42,43,47,48. This
implies that patients have had medically unsolved disorders
for a long time, have continued searching for a diagnosis and
treatment, or are being erroneously diagnosed and
managed49. One possible explanation is that dorsal/lumbar
pain is a frequent symptom occurring in various conditions,
and is one of the most common symptoms attributable to
6 The Journal of Rheumatology 2017; 44:2; doi:10.3899/jrheum.160825
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Table 3. Quality of the studies of diagnosis delay in spondyloarthritis evaluated with STROBE.
Author (yr)ref STROBE–positive Items Score
Conigliaro P (2016)26 1a), 1b), 2, 3, 4, 5, 6a), 7, 12a), 12b), 12d), 12e), 13a), 14a), 15, 16a), 17, 18, 20, 21 high
Bandinelli F (2016)23 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 11, 12a), 12b), 12e), 13a), 14a), 15, 16a), 16b), 17, 18, 20, 21, 22 high
Seo M (2015)27 1a), 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 11, 12a), 12b), 12e), 13a), 14a), 15, 16, 17, 18, 19, 20, 21, 22 high
Shahlaee A (2015)28 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 12a), 12e), 13a), 14a), 15, 16a), 18, 19, 20, 21, 22 high
Zhao J (2015)29 1a), 1b), 2, 3, 4, 5, 6a), 7, 8, 12a), 12b), 12c), 13a), 14a), 15, 16a), 17, 18, 19, 20, 21 high
Guan M (2014)30 1b), 2, 3, 7, 8, 12a), 12b), 12e), 13a), 14a), 15, 16a), 18, 19, 20 low
Bodur H (2012)21 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 12a), 12b), 12e), 13a), 14a), 15, 16a), 17, 18, 20, 21, 22. high
Ibn Yacoub Y (2012)31 1b), 2, 3, 4, 6a), 7, 8, 11, 12a), 12b), 13a), 15, 16a), 18, 20, 21, 22 medium
Gerdan V (2012)32 1b), 2, 3, 5, 6a), 7, 12a), 12e), 14a), 15, 16a), 17, 18, 19, 20, 21 medium
Hamilton L (2011)33 1b), 2, 3, 4, 5, 6a), 7, 8, 12a), 13a), 14a), 15, 16a), 17, 18, 19, 20, 21, 22 medium
Hajialilo M (2014)34 1a), 1b), 2, 3, 4, 5, 6a), 8, 12a),  12e), 13a), 14a), 15, 16a), 18, 19, 20, 21, 22 high
Chung HY (2011)35 1b), 2, 3, 4, 5, 6a), 7, 8, 11, 12a), 12b), 12e), 13a), 14a), 15, 16a), 17, 18, 19, 20, 21, 22  high
Slobodin G (2011)36 1b), 2, 3, 5, 6a), 7, 8, 11, 13a), 14b), 15, 16a), 18, 19, 22 medium
Roussou E (2011)37 1b), 2, 3, 5, 6a), 7, 8, 12a), 13a), 15, 16a), 18, 20, 22 medium
Ma HJ (2012)22 1b), 2, 3, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 14a), 14b), 15, 16a), 16b), 18, 19, 20, 22 medium
Almodóvar R (2011)14 1a), 1b), 2, 3, 4, 5, 6a), 7, 8,12a), 12b), 13a), 14a), 15, 16a), 18, 19, 20 medium
Bakland G (2011)38 1b), 2, 3, 4, 5, 6a), 6b), 7, 8, 9, 10, 11, 12a), 12b), 13a), 14a), 15, 16a), 16b), 17, 18, 19, 20, 21, 22 high
Cansu DU (2011)15 1b), 2, 3, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 14a), 15, 16a), 18, 19, 20, 21, 22 high
Bakland G (2011)16 1a), 1b), 2, 3, 5, 6a), 7, 8, 11, 12a), 12b), 12c), 13a),14a),15, 16a), 17, 18, 19, 20, 21 high
Almodóvar R (2010)13 1a), 1b), 2, 3, 4, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 14a),15, 16a), 16b), 17, 18, 20 high
Atagunduz P (2010)19 1a), 1b), 2, 3, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 15, 16a), 17, 18, 19, 20, 21 high
Ozgocmen S (2009)39 2,3, 4, 5, 6a),  7,8, 12a), 12e), 13a), 14a), 18, 19  low
Nazarinia MA (2009)12 1b), 2, 3, 5, 6a), 7, 8, 12a), 13a), 13b), 15, 18, 20, 21, 22 medium
Lin YC (2009)40 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 12a), 12e), 13a), 14a), 15, 16a), 17, 18, 19, 20, 21 high
Aggarwal R (2009)8 1b), 2, 3, 5, 6a), 7, 8, 11, 13a), 14a),15, 16a), 17, 18, 19, 20, 21, 22 medium
Dincer U (2008)41 1a), 1b), 2, 3, 7, 8, 12a), 12b), 12e), 13a), 14a), 15, 16a), 18, 19, 20 medium
Reed MD (2008)42 1a), 1b), 2, 3, 4, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 14a), 14b), 15, 16a), 16b), 18, 19, 20, 21 high
Forejtová S (2008)11 1b), 2, 3, 4, 5, 6a), 7, 8, 11, 12a), 12b), 13a), 14a), 15, 16a), 16b), 17, 18, 19, 20, 22 high
Lin Z (2008)43 1b), 2, 8, 12a), 13, 18 low
Aloush V (2007)18 1b), 2, 3, 4, 6a), 7, 8, 13a), 14a), 14b), 15, 18, 20 low
Uppal SS (2006)20 1b), 2, 5, 6a),  7, 8, 11, 12b), 13a), 14a), 14b), 15, 16a), 18 medium
Stone M (2005)44 1a), 1b), 2, 3, 4, 5, 6a), 7, 8, 10, 11, 12a), 12b), 13a), 14a), 15, 16a), 16b), 17, 18, 19, 20, 21 high
Feldtkeller E (2003)45 1b), 4, 6a), 12a), 13a), 13b), 15, 16a), 18, 19, 20 low
Zink A (2000)17 1b), 2, 3, 5, 6a), 7, 8, 10, 12a), 12b), 13a), 14a), 15, 16a), 16b), 18, 19, 20, 21 medium
Koh WH (1993)46 1b), 5, 6a), 8, 13a), 14b), 15, 16b), 18, 20 low
Carbone LD (1992)3 1a), 1b), 2, 3, 5, 6a), 7, 10, 12a), 13a), 14a), 15, 16a), 16b), 18, 19, 20 medium
Ringsdal VS (1989)47 1b), 5, 6a), 7, 12c), 13a), 14b), 15, 16a), 18, 19, 20 low
Calin A (1988)2 1b), 2, 3, 4, 5, 6a), 6b), 11, 13a), 14a), 15, 18, 19, 20, 21 low
Riesco M (1985)9 1b), 7, 8, 14a), 15, 18, 20 low
Marks SH (1983)48 1a), 1b), 2, 3, 4, 6a), 6b), 12d), 13a), 14a), 14b), 15, 16a), 18, 19, 20, 21 medium
Goodman CE (1980)10 1b), 2, 3, 14a), 15, 18, 20 low
Hill HF (1976)1 2, 3, 6a), 14a), 14b), 15, 18, 20, 22 low
STROBE: Strengthening The Reporting of OBservational studies in Epidemiology. Score quality: low quality < 50%; medium: 50% ≥ scoring < 70%; high:
70% ≥ scoring < 90%; excellent ≥ 90%.
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unsolved disorders that challenge physicians’ skills to
evaluate patients and give a diagnosis such as SpA as the
cause of pain.
This situation is more frequent in women than in men,
which is unexpected because the most common clinical
manifestations of SpA in both sexes were dorsal and/or lumbar
pain followed by peripheral arthritis, with similar prevalence
at onset, so diagnostic delay should not have differed.
The longer diagnostic delay in women may be related to
a lack of familiarity with the disease in women47,48, because
the prototypic SpA, AS, is predominately a male disease and
this has received wide attention. Although the disability rate
is worse in women than in men at all ages17, women are
identified as less disabled and with better spinal mobility than
men42. These differences and the slower progression of radio-
logical changes in women may influence earlier diagnosis in
men, because the spine is more severely affected in them31.
Consequently, the disease is not suspected in women, and a
wrong diagnosis or “non-specific symptoms and signs” is
given in healthcare records49.
According to the theory of knowledge, underdiagnosed
SpA in women might be due to a biased viewpoint of the
physician as observer. Some symptoms of SpA, such as low
back pain, morning stiffness, and sleep disorders associated
with pain are shared with fibromyalgia (FM)18 and have
traditionally been assigned low status in the cultural hierarchy
of medicine. Often, these symptoms in women are not
regarded as having the same meaning as similar symptoms
in men and they are not usually considered in the differential
diagnosis of SpA, in spite of sometimes coexisting with
enthesitis and peripheral arthritis8, sometimes misdiagnosed
as FM36,42. Further, SpA in women may be confused and
patients referred to gynecology, surgery, gastroenterology36,
or psychiatry10.
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Figure 2. Forest plot of the differences between the mean diagnosis delay of spondyloarthritis in women versus men according to published papers. Method
performed through inverse-variance by means of random-effect or fixed-effect, according to heterogeneity. A. Including 14 papers and 17 samples before the
sensitivity analysis. B. Including 13 papers and 16 samples after the sensitivity analysis.
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The quality of the research on SpA has increased since
2005, and the use of Assessment of SpondyloArthritis
International Society criteria has improved the operative
definition of this family of diseases, a development that will
facilitate comparison between the sexes. However, in the
papers reviewed, sex-related differences in delay of diagnosis
of SpA may be true or artificial owing to methodological
reasons, such as the publication bias observed. Moreover,
because the most frequent source of information was the
hospital, selection bias is also a possibility, which would
affect sex-related differences in diagnostic delay because
women patients with SpA would not be recognized at the
primary healthcare level and would not be referred to
rheumatology clinics, where the research was conducted. In
addition, there is a lack of information about how study
samples were calculated and how missing data were
addressed; only 1 paper described attempts to address
potential sources of bias38. The low score for quality obtained
for the papers was largely related to the methods section.
Most of the study designs were descriptive and cross-
sectional without strong inferential power. Only 1 paper
analyzed a case control study of patients with AS, finding a
longer delay in diagnosis in women48. Another method-
ological challenge is related to the lack of sex-stratified
results in most studies of diagnostic delay in SpA; influences
of sex were rarely discussed. Studies without sex-stratified
findings are easier to conduct; even so, some reflection is
required on the part of both authors and editors on the reasons
for producing and publishing such a large percentage of these
studies. 
The results of the studies analyzed present some limita-
tions. They provide only a partial picture of worldwide
attempts to identify the causes of sex-related differences
regarding diagnostic delay in SpA. Few of the articles
presented an empirical analysis of the information, and only
one-third of them reported a sex analysis or comparison of
diagnostic delay in SpA. In the case of studies focusing exclu-
sively on men, which was an exclusion criterion of this review,
this proportion would clearly be even lower. The above reflects
the near-absence of scientific studies on this issue; it also
restricts our ability as researchers to draw meaningful conclu-
sions about the nature of research on the topic.
Another limitation is that, although SpA has more
measures of disease than the ones we compared, such as
blood tests, radiographic studies, and functional measures,
we chose for this review those most frequently described in
the papers such as clinical and demographic characteristics.
Regarding juvenile arthritis, we offer data together with adult
onset; although there are some papers that include juvenile
onset, only 6 of them6,22,30,39,40,44 offer diagnostic delay
disaggregated between juvenile and adult onset of disease.
About excluding patients with PsA, there is 1 study37 in this
review in which some patients in the sample may have this
disease.
From a perspective of sex differences, this review was
limited to a number of factors related to family history and
HLA-B27, age at onset of symptoms, and at diagnosis, and
years of diagnostic delay. No analysis was conducted of
information reported by the authors about the influence of
social conditions on the delay. This aspect is crucial to under-
standing whether diagnostic delay is related to the sex context
of the female patient (i.e., personal/family history related to
productive/reproductive roles on the basis of the delay in the
demand for healthcare), or due to unfamiliarity with SpA in
women by physicians from primary care or other levels of
healthcare. The influence of social conditions was not
normally included although it was discussed in a few
papers8,23,27,30,31,32,34. It is a classic sex bias in which the
research approach de-contextualizes women’s health risks,
blocking new knowledge about the chain of responsibility, in
this case related to sex-related differences in diagnostic delay
in SpA. 
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Figure 3.Assessing publication bias of the published papers on diagnosis delay of spondyloarthritis in women versus men (funnel plot). A. Before sensitivity
analysis. B. After sensitivity analysis.
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Serious and important consequences of sex bias have been
described for women’s health in relation to clinical
management50. It is possible that medical knowledge has
been built up over the decades in ways that yield a disease
classification more suited to men’s complaints and health
problems, and signs or symptoms indicative of specific
conditions. Patients classified as having nonspecific signs and
symptoms may in fact have an identifiable disease, either at
an early stage not identified by contemporary (male-based)
diagnostic criteria or because they present an atypical
(non-male) set of symptoms for the disease. No treatment, or
incorrect treatment, at this point can lead to a worsening of
the disease, particularly among women50. There is probably
a lack of knowledge about sex-related aspects of SpA in the
medical community, with consequent delays in diagnosis and
suitable treatment. More information is required about
probably unfounded sex differences in diagnostic delay, such
as the number of previous erroneous diagnoses and treat-
ments, and doctors visited, all of which are important factors
to achieve the principle of equity in healthcare provision.
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